Email this article 
Prediction and Management of Preeclampsia: Literature Review
Abstract
Preeclampsia is a frequent complication of pregnancy. It is a multi-organ sickness that stays one of the predominant causes of maternal morbidity and mortality. Additionally, preeclampsia leads to many problems that can appear in the fetus or newborn. Preeclampsia occurs in about 1 in 20 pregnant women. This review focuses on the prediction of preeclampsia in women, the use of a number of biomarkers, in particular, a factor combining the use of soluble FMS-like tyrosinokinase-1 (sFlt-1) and placental growth factor (PlGF). A low value of the sFlt-1/PlGF ratio guidelines the incidence of preeclampsia within 4 weeks of the test result, and its high value predicts the incidence of preeclampsia within 1 week. The assessment additionally highlights different factors, such as pregnancy-associated plasma protein A, placental protein 13, disintegrin and metalloprotease 12, b-human chorionic gonadotropin, inhibin-A, soluble endoglin, nitric oxide, and growth differentiation factor 15. Biomarker checking out gives dependable and affordable screening techniques for early detection, prognosis, and monitoring of preeclampsia. Early diagnosis in groups of women at high risk for preeclampsia permits for speedy intervention, stopping the undesirable outcomes of preeclampsia. However, in addition research is wished to validate and optimize the use of biomarkers for extra correct prediction and diagnosis. This article objectives to evaluation the function of biomarkers, such as the sFlt1/PlGF ratio, in the prognosis and management of preeclampsia.
Keywords
Full Text:
PDFReferences
- Hackelöer, Max, Leon Schmidt, and Stefan Verlohren. "New advances in prediction and surveillance of preeclampsia: role of machine learning approaches and remote monitoring." Archives of gynecology and obstetrics 308.6 (2023): 1663-1677.
- Rana, Sarosh, Suzanne D. Burke, and S. Ananth Karumanchi. "Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders." American journal of obstetrics and gynecology 226.2 (2022): S1019-S1034.
- Magee, Laura A., Kypros H. Nicolaides, and Peter Von Dadelszen. "Preeclampsia." New England Journal of Medicine 386.19 (2022): 1817-1832.
- Cantwell, Roch, et al. "Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom." BJOG: an international journal of obstetrics and gynaecology 118 (2011): 1-203.
- Gyselaers, Wilfried. "Preeclampsia is a syndrome with a cascade of pathophysiologic events." Journal of clinical medicine 9.7 (2020): 2245.
- Zhang, Jun, Mark A. Klebanoff, and James M. Roberts. "Prediction of adverse outcomes by common definitions of hypertension in pregnancy." Obstetrics & Gynecology 97.2 (2001): 261-267.
- Espinoza, J., et al. "ACOG practice bulletin no. 202: gestational hypertension and preeclampsia." Obstet Gynecol 133.1 (2019): e1-25.
- American College of Obstetricians and Gynecologists. "ACOG Practice Bulletin No. 222: gestational hypertension and preeclampsia." Obstet Gynecol 135.6 (2020): e237-e260.
- Brown, Mark A., et al. "Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice." Hypertension 72.1 (2018): 24-43.
- Magee, Laura A., et al. "Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary." Journal of Obstetrics and Gynaecology Canada 36.5 (2014): 416-438.
- Turbeville, Hannah R., and Jennifer M. Sasser. "Preeclampsia beyond pregnancy: long-term consequences for mother and child." American Journal of Physiology-Renal Physiology 318.6 (2020): F1315-F1326.
- Phipps, Elizabeth, et al. "Preeclampsia: updates in pathogenesis, definitions, and guidelines." Clinical Journal of the American Society of Nephrology 11.6 (2016): 1102-1113.
- Karrar, Shahd A., Daniel J. Martingano, and Peter L. Hong. "Preeclampsia." StatPearls [Internet]. StatPearls Publishing, 2024.
- Burton, Graham J., et al. "Pre-eclampsia: pathophysiology and clinical implications." Bmj 366 (2019).
- Rybak-Krzyszkowska, Magda, et al. "From Biomarkers to the Molecular Mechanism of Preeclampsia—A Comprehensive Literature Review." International Journal of Molecular Sciences 24.17 (2023): 13252.
- Pijnenborg, Robert. "The placental bed." Hypertension in pregnancy 15.1 (1996): 7-23.
- Pijnenborg, Robert. "Trophoblast invasion and placentation in the human: morphological aspects." Trophoblast invasion and endometrial receptivity: novel aspects of the cell biology of embryo implantation. Boston, MA: Springer US, 1990. 33-47.
- Strickland, Sidney, and William G. Richards. "Invasion of the trophoblasts." Cell 71.3 (1992): 355-357.
- Khong, T. Yee, I. Hilary Sawyer, and Andrew R. Heryet. "An immunohistologic study of endothelialization of uteroplacental vessels in human pregnancy-evidence that endothelium is focally disrupted by trophoblast in preeclampsia." American journal of obstetrics and gynecology 167.3 (1992): 751-756.
- Lam, Chun, Kee-Hak Lim, and S. Ananth Karumanchi. "Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia." Hypertension 46.5 (2005): 1077-1085.
- Wang, Weikai, et al. "Meta-analysis of cardiovascular risk factors in offspring of preeclampsia pregnancies." Diagnostics 13.4 (2023): 812.
- Anto, Enoch Odame, et al. "Prevalence of preeclampsia and algorithm of adverse foeto-maternal risk factors among pregnant women in the Central Region of Ghana: A multicentre prospective cross-sectional study." PLoS One 18.6 (2023): e0288079.
- Sande, Anne Kvie, et al. "Pregestational maternal risk factors for preterm and term preeclampsia: A population‐based cohort study." Acta Obstetricia et Gynecologica Scandinavica 102.11 (2023): 1549-1557.
- Tyrmi, Jaakko S., et al. "Genetic risk factors associated with preeclampsia and hypertensive disorders of pregnancy." JAMA cardiology 8.7 (2023): 674-683.
-Verlohren, Stefan, et al. "Clinical interpretation and implementation of the sFlt-1/PlGF ratio in the prediction, diagnosis and management of preeclampsia." Pregnancy hypertension 27 (2022): 42-50.
- Zeisler, Harald, et al. "Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia." New England Journal of Medicine 374.1 (2016): 13-22.
- Rana, Sarosh, et al. "Clinical characterization and outcomes of preeclampsia with normal angiogenic profile." Hypertension in pregnancy 32.2 (2013): 189-201.
- Creswell, Lyndsay, et al. "Perspectives on the Use of Placental Growth Factor (PlGF) in the Prediction and Diagnosis of Pre-Eclampsia: Recent Insights and Future Steps." International Journal of Women's Health (2023): 255-271.
- Tsiakkas, A., et al. "Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history." Ultrasound in obstetrics & gynecology 45.5 (2015): 591-598.
- Chau, Katrina, Annemarie Hennessy, and Angela Makris. "Placental growth factor and pre-eclampsia." Journal of human hypertension 31.12 (2017): 782-786.
- Chau, Katrina, Annemarie Hennessy, and Angela Makris. "Placental growth factor and pre-eclampsia." Journal of human hypertension 31.12 (2017): 782-786.
- Karpova, Nataliia Sergeevna, Olga Pavlovna Dmitrenko, and Tatyana Sergeevna Budykina. "Literature review: The sFlt1/PlGF ratio and pregestational maternal comorbidities: New risk factors to predict pre-eclampsia." International Journal of Molecular Sciences 24.7 (2023): 6744.
- Roberts, James M., and Augustine Rajakumar. "Preeclampsia and soluble fms-like tyrosine kinase 1." The Journal of Clinical Endocrinology & Metabolism 94.7 (2009): 2252-2254.
- Maynard, Sharon E., et al. "Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia." The Journal of clinical investigation 111.5 (2003): 649-658.
- Levine, Richard J., et al. "Circulating angiogenic factors and the risk of preeclampsia." New England journal of medicine 350.7 (2004): 672-683.
- Verlohren, Stefan, et al. "The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients." American journal of obstetrics and gynecology 206.1 (2012): 58-e1.
- Verlohren, Stefan, et al. "New gestational phase–specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia." Hypertension 63.2 (2014): 346-352.
- Stepan, H., et al. "Clinical utility of sFlt‐1 and PlGF in screening, prediction, diagnosis and monitoring of pre‐eclampsia and fetal growth restriction." Ultrasound in Obstetrics & Gynecology 61.2 (2023): 168-180.
- Andersen, Lise Lotte Torvin, et al. "Decision Threshold for Kryptor sFlt‐1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting." Journal of the American Heart Association 10.17 (2021): e021376.
- Álvarez-Fernández, Indira, et al. "New biomarkers in diagnosis of early onset preeclampsia and imminent delivery prognosis." Clinical Chemistry and Laboratory Medicine (CCLM) 52.8 (2014): 1159-1168.
- Zeisler, Harald, et al. "Soluble fms-like tyrosine kinase-1-to-placental growth factor ratio and time to delivery in women with suspected preeclampsia." Obstetrics & Gynecology 128.2 (2016): 261-269.
- Soundararajan, Revathi, et al. "Real life outpatient biomarker use in management of hypertensive pregnancies in third trimester in a low resource SeTting: ROBUST study." Pregnancy Hypertension 23 (2021): 97-103.
- Zeisler, Harald, et al. "Soluble fms‐like tyrosine kinase‐1 to placental growth factor ratio: ruling out pre‐eclampsia for up to 4 weeks and value of retesting." Ultrasound in Obstetrics & Gynecology 53.3 (2019): 367-375.
- Peguero, A., et al. "Added prognostic value of longitudinal changes of angiogenic factors in early‐onset severe pre‐eclampsia: a prospective cohort study." BJOG: An International Journal of Obstetrics & Gynaecology 128.2 (2021): 158-165.
- Dröge, Lisa Antonia, et al. "Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study." Hypertension 77.2 (2021): 461-471.
- Jeon, Hae Rin, et al. "sFlt‐1/PlGF ratio as a predictive and prognostic marker for preeclampsia." Journal of Obstetrics and Gynaecology Research 47.7 (2021): 2318-2323.
- Satorres, Elena, Alicia Martínez-Varea, and Vicente Diago-Almela. "sFlt-1/PlGF ratio as a predictor of pregnancy outcomes in twin pregnancies: A systematic review." The Journal of Maternal-Fetal & Neonatal Medicine 36.2 (2023): 2230514.
- De La Calle, Maria, et al. "Gestational age-specific reference ranges for the sFlt-1/PlGF immunoassay ratio in twin pregnancies." Fetal Diagnosis and Therapy 48.4 (2021): 288-296.
- Zeisler, Harald, et al. "Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia." New England Journal of Medicine 374.1 (2016): 13-22.
- Gathiram, P., and J. J. C. J. O. A. Moodley. "Pre-eclampsia: its pathogenesis and pathophysiolgy: review articles." Cardiovascular journal of Africa 27.2 (2016): 71-78.
- Luewan, Suchaya, et al. "Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia." Singapore medical journal 59.1 (2018): 55.
- Fruscalzo, Arrigo, et al. "First trimester PAPP-A serum levels and long-term metabolic outcome of mothers and their offspring." Scientific Reports 10.1 (2020): 5131.
- Wu, Yifan, Yang Liu, and Yiling Ding. "Predictive performance of placental protein 13 for screening preeclampsia in the first trimester: a systematic review and meta-analysis." Frontiers in medicine 8 (2021): 756383.
- Gadde, Ranjeeta, Dayanand Cd, and S. R. Sheela. "Placental protein 13: An important biological protein in preeclampsia." Journal of circulating biomarkers 7 (2018): 1849454418786159.
- Vasilache, Ingrid-Andrada, et al. "Predictive performance of first trimester serum galectin 13/PP 13 in preeclampsia screening: A systematic review and meta analysis." Experimental and Therapeutic Medicine 23.6 (2022): 1-12.
- Andres, Faith, et al. "A disintegrin and metalloproteinase 12 (ADAM12) is reduced at 36 weeks’ gestation in pregnancies destined to deliver small for gestational age infants." Placenta 117 (2022): 1-4.
- Goetzinger, Katherine R., et al. "Efficiency of first‐trimester uterine artery Doppler, a‐disintegrin and metalloprotease 12, pregnancy‐associated plasma protein a, and maternal characteristics in the prediction of preeclampsia." Journal of Ultrasound in Medicine 32.9 (2013): 1593-1600.
- Choudhury, Kanika Mandi, et al. "Value of Serum beta-hCG in Pathogenesis of Pre-Eclampsia." Journal of Clinical Gynecology and Obstetrics 1.4-5 (2012): 71-75.
- Åsvold, B. O., et al. "Concentrations of human chorionic gonadotrophin in very early pregnancy and subsequent pre-eclampsia: a cohort study." Human reproduction 29.6 (2014): 1153-1160.
- Farzaneh, Farah, et al. "Value of α-fetoprotein, β-HCG, inhibin A, and UE3 at second trimester for early screening of preeclampsia." Asian Pacific Journal of Reproduction 8.1 (2019): 30-33.
- Yue, Chao-Yan, et al. "Are serum levels of inhibin A in second trimester predictors of adverse pregnancy outcome?." Plos one 15.5 (2020): e0232634.
- Neuman, Rugina I., et al. "PAPP‐A2 and inhibin a as novel predictors for pregnancy complications in women with suspected or confirmed preeclampsia." Journal of the American Heart Association 9.19 (2020): e018219.
- Margioula-Siarkou, Georgia, et al. "Soluble endoglin concentration in maternal blood as a diagnostic biomarker of preeclampsia: A systematic review and meta-analysis." European Journal of Obstetrics & Gynecology and Reproductive Biology 258 (2021): 366-381.
- Muhammed, Lamyaa Taha, Eham Amer Ali, and H. Hameed. "Role of soluble endoglin in the diagnosis of preeclampsia severity in Iraqi women." Syst. Rev. Pharm 12 (2021): 301-305.
- Perucci, Luiza O., et al. "Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia." PloS one 9.5 (2014): e97632.
- Duda, Dan G., Dai Fukumura, and Rakesh K. Jain. "Role of eNOS in neovascularization: NO for endothelial progenitor cells." Trends in molecular medicine 10.4 (2004): 143-145.
- Sugulle, Meryam, et al. "Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus." Hypertension 54.1 (2009): 106-112.
- Cruickshank, Tess, et al. "Circulating growth differentiation factor 15 is increased preceding preeclampsia diagnosis: implications as a disease biomarker." Journal of the American Heart Association 10.16 (2021): e020302.
- Odigboegwu, Obinnaya, Lu J. Pan, and Piyali Chatterjee. "Use of antihypertensive drugs during preeclampsia." Frontiers in cardiovascular medicine 5 (2018): 50.
- Podymow, Tiina, and Phyllis August. "Update on the use of antihypertensive drugs in pregnancy." Hypertension 51.4 (2008): 960-969.
- Garovic, Vesna D., et al. "Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association." Hypertension 79.2 (2022): e21-e41.
- Euser, Anna G., and Marilyn J. Cipolla. "Magnesium sulfate for the treatment of eclampsia: a brief review." Stroke 40.4 (2009): 1169-1175.
- Brindley, Beth A., and ROBERT J. SOKOL. "Induction and augmentation of labor: basis and methods for current practice." Obstetrical & gynecological survey 43.12 (1988): 730-743.
- Chappell, Lucy C., et al. "Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial." The Lancet 394.10204 (2019): 1181-1190.
- Chappell, Lucy C., et al. "Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial." The Lancet 394.10204 (2019): 1181-1190.
- Sachan, Rekha, et al. "Diagnostic Accuracy of Serum Glycosylated Fibronectin in Prediction of Preeclampsia: A Nested Case–Control Study." Annals of African Medicine 23.2 (2024): 169-175.
- Poon, Leona C., and Kypros H. Nicolaides. "Early prediction of preeclampsia." Obstetrics and gynecology international 2014.1 (2014): 297397.
- van Helden, Josef, and Ralf Weiskirchen. "Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia." Clinical biochemistry 48.16-17 (2015): 1113-1119.
- Espinoza, J., et al. "ACOG practice bulletin no. 202: gestational hypertension and preeclampsia." Obstet Gynecol 133.1 (2019): e1-25.
- Sibai, Baha M. "Treatment of hypertension in pregnant women." New England Journal of Medicine 335.4 (1996): 257-265.
- Magpie Trial Follow‐Up Study Collaborative Group. "The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre‐eclampsia. Outcome for children at 18 months." BJOG: An International Journal of Obstetrics & Gynaecology 114.3 (2007): 289-299.
- Villar, José, et al. "International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project." The Lancet 384.9946 (2014): 857-868.
- Bellamy, Leanne, et al. "Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis." Bmj 335.7627 (2007): 974.
- Villar, J., et al. "World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre‐eclampsia in populations of low nutritional status from developing countries." BJOG: An International Journal of Obstetrics & Gynaecology 116.6 (2009): 780-788.
- Smith, Devin D., and Maged M. Costantine. "The role of statins in the prevention of preeclampsia." American journal of obstetrics and gynecology 226.2 (2022): S1171-S1181.
- Costantine, Maged M., et al. "Letter by Costantine et al Regarding Article,“Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia”." Circulation 145.4 (2022): e115-e116.
- Committee on Obstetric Practice, and Society for Maternal-Fetal Medicine. "ACOG Committee Opinion No. 743: low-dose aspirin use during pregnancy." Obstet Gynecol 132.1 (2018): e44-52.
- Henderson, Jillian T., et al. "Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the US Preventive Services Task Force." Annals of internal medicine 160.10 (2014): 695-703.
- Henderson, Jillian T., et al. "Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality [Internet]." (2021).
- Sakowicz, Agata, et al. "New ideas for the prevention and treatment of preeclampsia and their molecular inspirations." International Journal of Molecular Sciences 24.15 (2023): 12100.
- Agarwal, Isha, and S. Ananth Karumanchi. "Preeclampsia and the anti-angiogenic state." Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 1.1 (2011): 17-21.
- Ai-ris, Y. Collier, Laura A. Smith, and S. Ananth Karumanchi. "Review of the immune mechanisms of preeclampsia and the potential of immune modulating therapy." Human immunology 82.5 (2021): 362-370.
- Atkinson, Jessica, et al. "Telehealth in antenatal care: recent insights and advances." BMC medicine 21.1 (2023): 332.
- Fazal, Nusrat, et al. "Telehealth: improving maternity services by modern technology." BMJ open quality 9.4 (2020): e000895.
- Palmer, Kirsten R., et al. "Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis." The Lancet 398.10294 (2021): 41-52.
- Paidas, Michael J., et al. "Prospective, randomized, double-blind, placebo-controlled evaluation of the pharmacokinetics, safety and efficacy of recombinant antithrombin versus placebo in preterm preeclampsia." American journal of obstetrics and gynecology 223.5 (2020): 739-e1.
- Brookfield, Kathleen F., et al. "Alternate dosing protocol for magnesium sulfate in obese women with preeclampsia: a randomized controlled trial." Obstetrics & Gynecology 136.6 (2020): 1190-1194.
- Culebras, Xavier, et al. "Advantages of intrathecal nalbuphine, compared with intrathecal morphine, after cesarean delivery: an evaluation of postoperative analgesia and adverse effects." Anesthesia & Analgesia 91.3 (2000): 601-605.
- Sharma, Dhruvikumari D., et al. "The Management of Preeclampsia: A Comprehensive Review of Current Practices and Future Directions." Cureus 16.1 (2024).
- Olesen, Charlotte, et al. "Effect of diuretics on fetal growth: a drug effect or confounding by indication? Pooled Danish and Scottish cohort data." British journal of clinical pharmacology 51.2 (2001): 153-157.
- Sharma, Dhruvikumari D., et al. "The Management of Preeclampsia: A Comprehensive Review of Current Practices and Future Directions." Cureus 16.1 (2024).
- Abazarnejad, Tayebe, et al. "Effectiveness of psycho-educational counseling on anxiety in preeclampsia." Trends in psychiatry and psychotherapy 41.3 (2019): 276-282.
- Machado, Michelle de Souza Rangel, et al. "Multiprofessional care promotes of quality of life in pregnant women with preeclampsia: a cross-sectional study." Clinics 75 (2020): e1951.
- Rigó Jr, János, et al. "[233-POS]: Postpartum depression and anxiety in hypertensive disorders of pregnancy." Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 5.1 (2015): 117-118.
- Umamah, Faridah, et al. "The effectiveness of psycho-educational counseling in pregnant women with preeclampsia: A systematic review." Journal of Public Health Research 11.3 (2022): 22799036221104161.
- Crovetto, Francesca, et al. "Effects of Mediterranean diet or mindfulness-based stress reduction on prevention of small-for-gestational age birth weights in newborns born to at-risk pregnant individuals: the IMPACT BCN randomized clinical trial." Jama 326.21 (2021): 2150-2160.
- Garti, Isabella, et al. "A socioecological description of the influencing factors to midwives’ management of preeclampsia in a Ghanaian tertiary hospital." PLoS One 18.9 (2023): e0291036.
- Santos, Leilani L., et al. "Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia." Placenta 103 (2021): 76-81.
- Emilda, Emilda, et al. "Midwifery strategies for preeclampsia: enhancing early detection and intervention for optimal maternal health." Path of Science 9.7 (2023): 2015-2022.
DOI: http://dx.doi.org/10.52155/ijpsat.v46.2.6593
Refbacks
- There are currently no refbacks.
Copyright (c) 2024 Maged Naser
This work is licensed under a Creative Commons Attribution 4.0 International License.